Chad Clark Talks EU Expansion With Clinical OMICs


Precision for Medicine President Chad Clark speaks with Alex Philippides of Clinical OMICs to discuss Precision’s European expansion. With the goal of better serving developers of cancer treatments worldwide, Clark outlines some of the challenges of conducting immune-oncology studies and defines some of the solutions that Precision now offers in the US and EU.

To read the complete article, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.